BONH
JAZZ icon

Bank of New Hampshire’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bank of New Hampshire’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$432K Buy
1,794
+116
+7% +$25.4K 0.09% 149
2026
Q1 		$317K Buy
+1,678
New +$293K 0.07% 161

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return

Bank of New Hampshire's JAZZ Position: Q2 2026 in Review

Bank of New Hampshire increased its Jazz Pharmaceuticals (JAZZ) stake by 6.9% in Q2 2026, buying an estimated $25.4K and bringing the position to 1,794 shares worth $432K. The position accounts for 0.09% of the portfolio, ranked #149.

Bank of New Hampshire first reported a position in JAZZ in Q1 2026 and has held it in 2 quarters since. 373 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Bank of New Hampshire held 1,794 shares of Jazz Pharmaceuticals worth $432K as of Q2 2026.
  • Bank of New Hampshire bought 116 Jazz Pharmaceuticals shares in Q2 2026, an estimated $25.4K.
  • Jazz Pharmaceuticals made up 0.09% of Bank of New Hampshire's portfolio in Q2 2026, its #149 holding.
  • Bank of New Hampshire first reported a position in Jazz Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 373 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Bank of New Hampshire's 13F filing for Q2 2026, filed 14 Jul 2026.